The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

A.Zh. Fursova

Novosibirsk State Regional Hospital;
Novosibirsk State Medical University

M.Yu. Zubkova

Novosibirsk State Regional Hospital;
Novosibirsk State Medical University

M.A. Vasilyeva

Novosibirsk State Regional Clinical Hospital;
Novosibirsk State Medical University

Yu.A. Karlash

Novosibirsk State Regional Hospital;
Novosibirsk State Medical University

I.F. Nikulich

Novosibirsk State Regional Clinical Hospital;
Novosibirsk State Medical University

A.S. Derbeneva

Novosibirsk State Regional Hospital;
Novosibirsk State Medical University

Optical coherence tomography in the diagnosis of multiple sclerosis

Authors:

A.Zh. Fursova, M.Yu. Zubkova, M.A. Vasilyeva, Yu.A. Karlash, I.F. Nikulich, A.S. Derbeneva

More about the authors

Journal: Russian Annals of Ophthalmology. 2024;140(3): 59‑68

DOI: 10.17116/oftalma202414003159

Read: 2070 times

Contact the author
Table of contents

OPTICAL COHERENCE TOMOGRAPHY IN THE DIAGNOSIS OF MULTIPLE SCLEROSIS
OPTICAL COHERENCE TOMOGRAPHY IN THE DIAGNOSIS OF MULTIPLE SCLEROSIS

To cite this article:

Fursova AZh, Zubkova MYu, Vasilyeva MA, Karlash YuA, Nikulich IF, Derbeneva AS. Optical coherence tomography in the diagnosis of multiple sclerosis. Russian Annals of Ophthalmology. 2024;140(3):59‑68. (In Russ.)
https://doi.org/10.17116/oftalma202414003159

Подписка 2026 Вестник офтальмологии (Russian Annals of Ophthalmology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Multiple sclerosis (MS) is a chronic autoimmune-inflammatory and neurodegenerative disease.

PURPOSE

This study explores the main structural changes in patients with MS and their relationships with the activity and type of disease course.

MATERIAL AND METHODS

This prospective study included 159 patients (318 eyes) with an established diagnosis of MS: group (44 eyes; 13.84%) — relapsing-remitting type MS (RRMS) lasting up to 1 year without a history of optic neuritis (ON); group 2 (30 eyes; 9.43%) — RRMS up to 1 year with ON; group 3 (56 eyes; 17.61%) — RRMS lasting from 1 to 10 years without ON; group 4 (38 eyes; 11.95%) — RRMS from 1 to 10 years with ON; group 5 (49 eyes; 15.41%) — RRMS >10 years without ON; group 6 (37 eyes; 11.63%) — RRMS >10 years with ON; group 7 (34 eyes; 10.69%) — secondary progressive multiple sclerosis (SPMS) without ON; group 8 (30 eyes; 9.43%) — SPMS with ON. Patients underwent standard ophthalmological examinations, including optical coherence tomography.

RESULTS

A decrease in structural parameters was diagnosed, progressing with the duration of the disease and the presence of ON: the minimum values of mGCL+IPL (65.83±9.14 μm) and mSNFL (76.37±14.77 μm) were detected in the group with SPMS with ON. High inverse correlations of EDSS with mGCL+IPL and mRNFL were demonstrated, with maximum in the group with the longest duration of MS without ON (–0.48 and -0.52 (p=0.01), respectively).

CONCLUSION

Changes in the thickness of the structural parameters of the retina, measured by OCT, can be considered as a predictor of the course of MS.

Keywords:

multiple sclerosis
optical coherence tomography
optic neuritis
extended disability rating scale

Authors:

A.Zh. Fursova

Novosibirsk State Regional Hospital;
Novosibirsk State Medical University

M.Yu. Zubkova

Novosibirsk State Regional Hospital;
Novosibirsk State Medical University

M.A. Vasilyeva

Novosibirsk State Regional Clinical Hospital;
Novosibirsk State Medical University

Yu.A. Karlash

Novosibirsk State Regional Hospital;
Novosibirsk State Medical University

I.F. Nikulich

Novosibirsk State Regional Clinical Hospital;
Novosibirsk State Medical University

A.S. Derbeneva

Novosibirsk State Regional Hospital;
Novosibirsk State Medical University

Received:

30.01.2024

Accepted:

18.03.2024

Close metadata

References:

  1. Frisch T, Elkjaer ML, Reynolds R, et al. Multiple Sclerosis Atlas: A Molecular Map of Brain Lesion Stages in Progressive Multiple Sclerosis. Netw Syst Med. 2020;3(1):122-129.  https://doi.org/10.1089/nsm.2020.0006
  2. Sheremet NL, Eliseeva DD, Kalashnikova AK, Zakharova MN. Typical and atypical optic neuritis. Russian Annals of Ophthalmology = Vestnik oftal’mologii. 2023; 139(6):175-182. (In Russ.). https://doi.org/10.17116/oftalma2023139061175
  3. Fursova AZh, Gamza YuA, Zubkova MYu, et al. Ophthalmological diagnostics at the onset and progression of neurodegenerative diseases. Russian Ophthalmological Journal = Rossiyskiy oftal’mologicheskiy zhurnal. 2021;14(1): 104-110. (In Russ.). https://doi.org/10.21516/2072-0076-2021-14-1-104-110
  4. Choi S, Guo L, Cordeiro MF. Retinal and Brain Microglia in Multiple Sclerosis and Neurodegeneration. Cells. 2021;10:1507. https://doi.org/10.3390/cells10061507
  5. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173. Epub 2017 Dec 21.  https://doi.org/10.1016/S1474-4422(17)30470-2
  6. Neurology: national guide [Nevrologiya: natsional’noye rukovodstvo]: in 2 volumes. Vol. 1. Eds Gusev E.I., Konovalov A.N., Skvortsova V.I. 2nd ed., processed and additional. M.: GEOTAR-Media; 2022;880. (National Guides Series). (In Russ.).
  7. Choi S, Guo L, Cordeiro MF. Retinal and Brain Microglia in Multiple Sclerosis and Neurodegeneration. Cells. 2021;10(6):1507. https://doi.org/10.3390/cells10061507
  8. Aboulenein-Djamshidian F, Serbecic N. OCT is an alternative to MRI for monitoring MS — NO. Mult Scler. 2018;24(6):703-705.  https://doi.org/10.1177/1352458518754366
  9. Svetozarskiy SN, Kopishinskaya SV, Ruina EA, Antipenko EA. Clinical phenotypes of optic nerve damage in patients with neuromyelitis optica spectrum disorder. Russian Annals of Ophthalmology = Vestnik oftal’mologii. 2023; 139(2):61-67. (In Russ.). https://doi.org/10.17116/oftalma202313902161
  10. Siger M, Owidzka M, Świderek-Matysiak M, et al. Optical Coherence Tomography in the Differential Diagnosis of Patients with Multiple Sclerosis and Patients with MRI Nonspecific White Matter Lesions. Sensors (Basel). 2021;21(21):7127. https://doi.org/10.3390/s21217127
  11. Papadopoulou A, Oertel FC, Zimmermann H, et al. Optische Kohärenztomografie bei Erkrankungen des zentralen Nervensystems [Optical Coherence Tomography in Disorders of the Central Nervous System]. Klin Monbl Augenheilkd. 2018;235(11):1242-1258. https://doi.org/10.1055/a-0715-7961
  12. Arnold DL, Calabresi PA, Kieseier BC, et al. Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis. BMC Neurol. 2014;14:240.  https://doi.org/10.1186/s12883-014-0240-x
  13. De Stefano N, Stromillo ML, Giorgio A, et al. Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2016;87(1):93-99.  https://doi.org/10.1136/jnnp-2014-309903
  14. Graham EC, You Y, Yiannikas C, et al. Progressive Loss of Retinal Ganglion Cells and Axons in Nonoptic Neuritis Eyes in Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study. Invest Ophthalmol Vis Sci. 2016;57(4):2311-2317. https://doi.org/10.1167/iovs.15-19047
  15. Bsteh G, Hegen H, Teuchner B, et al. Peripapillary retinal nerve fibre layer thinning rate as a biomarker discriminating stable and progressing relapsing-remitting multiple sclerosis. Eur J Neurol. 2019;26(6):865-871.  https://doi.org/10.1111/ene.13897
  16. Bsteh G, Hegen H, Teuchner B, et al. Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis. Mult Scler. 2019;25(2):196-203.  https://doi.org/10.1177/1352458517740216
  17. Huang-Link YM, Al-Hawasi A, Lindehammar H. Acute optic neuritis: retinal ganglion cell loss precedes retinal nerve fiber thinning. Neurol Sci. 2015; 36(4):617-620.  https://doi.org/10.1007/s10072-014-1982-3
  18. Bsteh G, Berek K, Hegen H, et al. Macular ganglion cell-inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis. Mult Scler. 2021;27(5):684-694.  https://doi.org/10.1177/1352458520935724
  19. Mirmosayyeb O, Yazdan Panah M, Mokary Y, et al. Optical coherence tomography (OCT) measurements and disability in multiple sclerosis (MS): A systematic review and meta-analysis. J Neurol Sci. 2023;454:120847. https://doi.org/10.1016/j.jns.2023.120847
  20. Esen E, Sizmaz S, Demir T, et al. Evaluation of Choroidal Vascular Changes in Patients with Multiple Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography. Ophthalmologica. 2016;235(2):65-71.  https://doi.org/10.1159/000441152
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.